Journal Information
Vol. 9. Issue 1.
Pages 19-32 (January - February 2003)
Share
Share
Download PDF
More article options
Vol. 9. Issue 1.
Pages 19-32 (January - February 2003)
ARTIGO ORIGINAL/ORIGINAL ARTICLE
Open Access
A determinação quantitativa da área de microvasos intratumorais pode ser um indicador útil para tratamento coadjuvante em carcinomas de células não pequenas operados do pulmão
Morphometric intratumoral microvessel area evaluation could be a useful indicator for coadjuvant therapy in ressected NSCLC
Visits
4715
Luciane Cristina Dreher Irion1, João Carlos Prolla2, Antônio Atalíbio Hartmann3, Vinícius Duval da Silva4
1 Mestre em Patologia pela Fundação Faculdade Federal de Ciências Médicas de Porto Alegre (FFFCMPA). Pós-graduanda (doutoramento em Patologia) na FFFCMPA. Porto Alegre, RS, Brasil. Este trabalho tem origem na dissertação de mestrado da autora.
2 Professor titular do Departamento de Medicina Interna da Faculdade de Medicina da Universidade Federal do Rio Grande do Sul (UFRGS). Professor orientador do programa de pós-graduação em Medicina: Patologia, FFFCMPA. Porto Alegre, RS, Brasil.
3 Professor adjunto do departamento de Patologia da FFFCMPA e professor co-orientador do programa de pós-graduação em Medicina: Patologia, FFFCMPA. Porto Alegre, RS, Brasil.
4 Professor do departamento de Patologia da Faculdade de Medicina da Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS).
This item has received

Under a Creative Commons license
Article information
RESUMO

Objectivo: Realizar a medida da área vascular tumoral e a contagem individual dos microvasos, demonstrados por imuno-histoquímica, em imagens de campos microscópicos de carcinoma de células não pequenas dos pulmões, verificando a correlação dessas medidas com a sobrevida dos pacientes. Tipo do estudo: transversal e observacional. Material e métodos: O material foi proveniente de peças cirúrgicas de 107 pacientes com carcinoma de células não pequenas dos pulmões tratados no Pavilhão Pereira Filho – Santa Casa de Porto Alegre. A partir de cortes de tecido incluídos em parafina, foi realizada imuno-histoquímica com o anticorpo monoclonal anti-CD 34 (clone QB-End10; DAKO Corporation). A área vascular tumoral e a contagem de microvasos foram obtidas com o auxílio do programa de computador Image Pro Plus – 3.0. Resultados: A sobrevida média, em cinco anos, nos casos com alta área vascular (utilizando a média das áreas como ponto de corte) foi 21,7 meses±2,5, sendo significativamente menor (P < 0,0001) do que os de baixa área vascular, com 38,9 meses±3,0. O coeficiente de correlação entre a medida de área de microvasos e a contagem numérica destes foi 0,5 (P = = 0,001). A área vascular tumoral apresentou maior correlação com a sobrevida (coef. correlação – 0,48/P=0,001) do que a contagem numérica dos microvasos tumorais (coef. de correlação – 0,2 / P=0,03). Não foi encontrada correlação significativa entre a medida de área de microvasos e classificação histológica do tumor, sistema TNM, estado linfonodal e estadiamento clínico. Conclusão: A medida de área vascular tumoral, estabelecida com auxílio de computador, pode ser utilizada como um factor prognóstico para o carcinoma de células não pequenas dos pulmões.

REV PORT PNEUMOL IX (1): 19-32

Palavras-chave:
Angiogénese
CD 34
Imuno-histoquímica
Carcinoma de células não pequenas dos pulmões
Análise de imagem
ABSTRACT

Objective: To accomplish the tumor vascular area measure and the microvessel count, shown by immunohistochemistry, in non small cell lung cancer (NSCLC) microscopic images, and verify the correlation between these measurements and patients survival. Design: cross-sectional and observational. Material and methods: The material was deriving from 107 NSCLC surgical specimens in Pavilhão Pereira Filho — Santa Casa, Porto Alegre. Immunohistochemistry with anti-CD 34 monoclonal antibody (QB-End10; DAKO Corporation) was performed on paraffin-embedded tissue sections. The tumoral vascular area and the microvessel count were obtained by Image Pro Plus – 3.0 program. Results: The 5-year survival rate of high vascular area group (the cut-off was the mean of areas) was 21.7months±2.5, significantly lower (P < 0.0001) than the low vascular area cases, 38.9months±3.0. The correlation coefficient between microvessel area and microvessel count was 0.5 (P=0.001). The tumoral vascular area shown higher correlation to survival (correlation coefficient: –0.48 / P=0.001) than the tumoral microvessel count (correlation coefficient: –0.2 / P=0.03). There was not any significant correlation between the microvessel areas and the histological type, the TNM, the lymph nodes status and the clinical staging. Conclusion: The tumoral vascular area measurement, with computed assistance, can be used as a prognostic marker in NSCLC.

REV PORT PNEUMOL IX (1): 19-32

Key-words:
Angiogenesis
CD 34
Immunohistochemistry
NSCLC
Image analysis
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
L. Antonangelo, F.D.C. Bernardi, V.L. Capelozzi, et al.
Morphometric evaluation of argyrophilic nucleolar organizer region is useful in predicting long-term survival in squamous cell carcinoma of the lung.
Chest, 111 (1997), pp. 110-114
[2.]
K. Matsuyama, Y. Chiba, M. Sasaki, H. Tanaka, R. Muraoka.
Tumor angiogenesis as a prognostic mar ker in operable non-small cell lung cancer.
Ann Thorac Surg, 65 (1998), pp. 1405-1409
[3.]
INCA - Instituto Nacional Do Cancer.
Relatório de atividades 2001.
[4.]
F.D.C. Bernardi, V.L. Capelozzi, T.Y. Takagaki, R.N. Younes, P.H.N. Saldiva.
Usefulness of morphometric evaluation of histopathologic slides in predicting long-term outcome of patients with squamous cell carcinoma of the lung, a preliminary report.
Chest, 107 (1995), pp. 614-620
[5.]
D. Quinlan, A. Davidson, C. Summers, H. Warden, H. Doshi.
Accumulation of p53 correlates with a poor prognosis in human lung cancer.
Cancer Res, 52 (1992), pp. 4828-4831
[6.]
Y. Chiba, T. Taniguchi, K. Matsuyama, et al.
Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma.
Surg Today, 29 (1999), pp. 1148-1153
[7.]
T. D’Amico, M. Massey, J.N. Herndon, M. Moore, D.J. Harpole.
A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.
J Cardiovasc Surg, 117 (1999), pp. 736-743
[8.]
L.M.M.F. Demarchi, M.M. Reis, S.A.P. Palomino, et al.
Prognostic Values of stromal proportion and PCNA, Ki-67, and p53 proteins with resected adenocarcinoma of the lung.
Mod Pathol, 13 (2000), pp. 511-520
[9.]
F.D. Bernardi, L. Antonangelo, R. Beyruti, T. Ta Kagaki, P.H. Saldiva, V.L. Capelozzi.
A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers.
Mod Pathol, 10 (1997), pp. 992-1000
[10.]
P.E. Carvalho, L. Antonangelo, F.D. Bernardi, L.E. Leao, O.R. Rodrigues, V.L. Capelozzi.
Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas.
Jpn J Clin Oncol, 30 (2000), pp. 478-486
[11.]
F. Folkman.
What is the evidence that tumors are angiogenesis dependent?.
J Natl Cancer Inst, 82 (1990), pp. 4-6
[12.]
G. Gasparini, N. Weidner, S. Maluta, et al.
Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma.
Int J Cancer, 55 (1993), pp. 739-744
[13.]
N. Weidner.
Tumor angiogenesis: Review of current applications in tumor prognostication.
Seminars in Diagnostic Pathology, 10 (1993), pp. 302-313
[14.]
P. Macchiarini, G. Fontanini, E. Dulmet, et al.
Angiogenesis: an indicator of metastasis in non-small-cell lung cancer invading the thoracic inlet.
Ann Thorac Surg, 57 (1994), pp. 1534-1539
[15.]
N. Weidner, J. Semple, W. Welch, J. Folkman.
Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma.
N Engl J Med, 324 (1991), pp. 1-8
[16.]
M. Toi, K. Inada, H. Suzuki, T. Tominaga.
Tumor angiogenesis in breast cancer: its importance as a prog nostic indicator and the association with vascular endothelial growth factor expression.
Breast Cancer Res Treat, 36 (1995), pp. 193-204
[17.]
N. Weidner, P. Carroll, J. Flax, W. Blumenfeld, J. Folkman.
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Am J Pathol, 143 (1993), pp. 401-409
[18.]
H. Hollingsworth, E. Kohn, S. Steinberg, M. Rothenberg, M. Merino.
Tumor angiogenesis in advanced stage ovarian carcinoma.
Am J Pathol, 147 (1995), pp. 33-41
[19.]
W. Tjalma, E. Van Marck, J. Weyler, et al.
Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer.
Br J Cancer, 78 (1998), pp. 170-174
[20.]
N. Tanigawa, H. Amaya, M. Matsumara, et al.
Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas.
Cancer Res, 56 (1996), pp. 2671-2676
[21.]
A. Srivastava, P. Laidler, R. Davies, K. Horgan, L. Hughes.
The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.00mm thick) skin melanoma. A quantitative histologic study.
Am J Pathol, 133 (1988), pp. 419-423
[22.]
K. Kim, B. Li, J. Winer, M. Armanini, N. Gillet, H.S. Phillips, N. Ferrara.
Nature, 362 (1993 Apr 29), pp. 841-844
[23.]
R. Strieter, P. Polverini, D. Arenberg, et al.
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer.
J Leukoc Biol, 57 (1995), pp. 752-762
[24.]
D. Carbone.
The biology of lung cancer.
Semin Oncol, 24 (1997), pp. 388-401
[25.]
P. Macchiarini, G. Fontanini, M. Hardin, N.I.F. Squarti, C. Angeletti.
Relation of neovascularization to metastasis of non small cell lung cancer.
Lancet, 340 (1992), pp. 145-146
[26.]
C. Angeletti, M. Lucchi, G. Fontanini, et al.
Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2).
[27.]
G. Cox, J. Jones, R. Walker, W. Steward, K. O’Byrne.
Angiogenesis and non-small cell lung cancer.
Lung Cancer, 27 (2000), pp. 81-100
[28.]
N. Voravud, N. Charuruk.
Tumor angiogenesis.
J Med Assoc Thai, 82 (1999), pp. 394-404
[29.]
L. Fina, H. Moolgaard, D. Robertson, et al.
Expression of the CD34 gene in vascular endothelial cells.
Blood, 75 (1990), pp. 2417-2426
[30.]
G. Fontanini, D. Bigini, S. Vignati, et al.
Microvessel count predicts metastatic disease and survival in nonsmall-cell lung cancer.
J Pathol, 177 (1995), pp. 57-63
[31.]
A. Giatromanolaki, M. Koukourakis, D. Theod Ossiou, et al.
Comparative evaluation of angiogenesis assessment with anti-factor VIII and anti-CD 31immu nostaining in non-small cell lung cancer.
Clin Cancer Res, 3 (1997), pp. 2485-2492
[32.]
P. Wesseling, A. Jeroen, W. Van Der Laak, M. Henk De Leenw, J. Rutter, P. Burger.
Quantitative immunohistochemical analysis of the microvasculature in untreated human glioblastoma multiforme.
J Neurosurg, 81 (1994), pp. 902-909
[33.]
P. Pavlopoulos, A. Konstantinidou, E. Agapitos, N. Kavantzas, P. Nikolopoulou, P. Davaris.
A morphometric study of neovascularization in colorectal carcinoma.
Cancer, 83 (1998), pp. 2067-2075
[34.]
W. Travis, T. Colby, B. Corrin, Y. Shimosato, E. Brambilla.
Histological typing of lung and pleural tumours.
WHO, World Health Organization, International Histological Classification of Tumours, pp. 156
[35.]
J. Brown, S. Spiro.
Update on lung cancer and mesothelioma.
J R Coll Physicians Lond, 33 (1999), pp. 506-512
[36.]
G. Fontanini, S. Vignati, D. Bigini, et al.
Neoangiogenesis: a putative marker of malignancy in non-smallcell lung cancer (NSCLC) development.
[37.]
G. Fontanini, M. Lucchi, S. Vignati, et al.
Angiogenesis as a prognostic indicator of survival in non-smallcell lung carcinoma: a prospective study.
J Natl Cancer Inst, 89 (1997), pp. 881-886
[38.]
V. Alves, C. Bacchi, J. Vassalo.
Manual de Imuno -histoquímica.
São Paulo: Sociedade Brasileira de Patologia, 270 (1999),
[39.]
P. Vermeulen, G. Gasparini, S. Fox, et al.
Quantifi cation of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation.
Eur J Cancer, 32A (1996), pp. 2474-2484
[40.]
D.J. Harpole, W. Richards, J. Herndon, D. Sugar Baker.
Angiogenesis in molecular biologic substaging in patients with stage I non-small-cell lung cancer.
Ann Thorac Surg, 61 (1996), pp. 1470-1476
[41.]
A. Giatromanolaki, M. Koukourakis, S. Kako Lyris, et al.
Vascular endothelial growth factor, wildtype p53, and angiogenesis in early operable non-small cell lung cancer.
Clin Cancer Res, 4 (1998), pp. 3017-3024
[42.]
A. Yuan, P. Yang, C. Yu, et al.
Tumor angiogenesis correlates with histologic type and metastasis in non-smallcell lung cancer.
Am J Respir Crit Care Med, 152 (1995), pp. 2157-2162
[43.]
A. Giatromanolaki, M. Koukourakis, K. O’Byrne, et al.
Prognostic value of angiogenesis in operable nonsmall-cell lung cancer.
[44.]
G. Fontanini, S. Vignati, M. Lucchi, et al.
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor VEGF) expression.
Br J Cancer, 75 (1997), pp. 1295-1301
[45.]
K. Yamazaki, S. Abe, H. Takekawa, et al.
Tumor angiogenesis in human lung andecarcinoma.
Cancer, 74 (1994), pp. 2245-2250
[46.]
C. Dazzi, A. Cariello, P. Maioli, et al.
Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer.
Lung Cancer, 24 (1999), pp. 81-88
Copyright © 2003. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?